Trial Outcomes & Findings for Evaluation of Deposits on Contact Lenses Worn Daily Wear (NCT NCT00725153)

NCT ID: NCT00725153

Last Updated: 2012-08-23

Results Overview

Film and discrete deposits were assessed with a slit-lamp after 10 hours of lens wear. Film deposits were recorded on a 5-point scale, where 0=no deposition, clean surface; 1=slight, deposition occupying 1-5% of lens front surface; 2=mild, deposition occupying 6-15% of lens front surface; 3=moderate, deposition occupying 16-25% of lens front surface; 4=severe, deposition occupying \>25% of lens front surface. Discrete deposits were recorded on a 5-point scale, where 0=no deposition, clean surface; 1=microdeposits (less than or equal to 10 dots); 2=microdeposits (greater than 10 dots); 3=macro deposits; 4=one or more jelly bumps. Participants were classified into Front Surface Lens Deposits \<2 (less than grade 2 for both film and discrete) and into front surface lens deposits \>1 (greater than grade 1 for either film, discrete, or both).

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

55 participants

Primary outcome timeframe

10 hours

Results posted on

2012-08-23

Participant Flow

55 Subjects currently wearing hydrogel or silicone hydrogel lenses were recruited at 3 US and 1 United Kingdom study sites.

Subjects randomized by lens order to wear PureVision and Acuvue 2 lenses for 10 hours each.

Participant milestones

Participant milestones
Measure
PureVision / Acuvue 2
PureVision lenses worn in Period One, Acuvue 2 lenses worn in Period Two. Both products worn for 10 hours each.
Acuvue 2 / PureVision
Acuvue 2 lenses worn in Period One, PureVision lenses worn in Period Two. Both products worn for 10 hours each.
Period One, 10 Hours of Wear
STARTED
27
28
Period One, 10 Hours of Wear
COMPLETED
27
28
Period One, 10 Hours of Wear
NOT COMPLETED
0
0
Period Two, 10 Hours of Wear
STARTED
27
28
Period Two, 10 Hours of Wear
COMPLETED
27
28
Period Two, 10 Hours of Wear
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Evaluation of Deposits on Contact Lenses Worn Daily Wear

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Overall
n=55 Participants
All enrolled participants
Age Continuous
31.95 years
STANDARD_DEVIATION 12.03 • n=5 Participants
Sex: Female, Male
Female
42 Participants
n=5 Participants
Sex: Female, Male
Male
13 Participants
n=5 Participants

PRIMARY outcome

Timeframe: 10 hours

Population: All enrolled participants.

Film and discrete deposits were assessed with a slit-lamp after 10 hours of lens wear. Film deposits were recorded on a 5-point scale, where 0=no deposition, clean surface; 1=slight, deposition occupying 1-5% of lens front surface; 2=mild, deposition occupying 6-15% of lens front surface; 3=moderate, deposition occupying 16-25% of lens front surface; 4=severe, deposition occupying \>25% of lens front surface. Discrete deposits were recorded on a 5-point scale, where 0=no deposition, clean surface; 1=microdeposits (less than or equal to 10 dots); 2=microdeposits (greater than 10 dots); 3=macro deposits; 4=one or more jelly bumps. Participants were classified into Front Surface Lens Deposits \<2 (less than grade 2 for both film and discrete) and into front surface lens deposits \>1 (greater than grade 1 for either film, discrete, or both).

Outcome measures

Outcome measures
Measure
PureVision Contact Lenses
n=55 Participants
PureVision lenses worn 10 hours
Acuvue 2 Contact Lenses
n=55 Participants
Acuvue 2 lenses worn 10 hours
Front Surface Lens Deposits
Deposits Graded <2
27 Participants
32 Participants
Front Surface Lens Deposits
Deposits Graded >1
28 Participants
23 Participants

Adverse Events

PureVision Lenses Worn 10 Hours

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Acuvue 2 Lenses Worn 10 Hours

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Jessie Lemp, MS

Alcon Research, Ltd.

Phone: 817-615-2739

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place

Restriction type: LTE60